Sulfatides in ovarian tumors: Clinicopathological correlates

International Journal of Gynecological Cancer

Volumn 14, Issue 1, 2004, Pages 89-93

  Makhlouf, Ahmed Mohammad ^a   Fathalla, M M ^a   Zakhary, M A ^a   Makarem, M H ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Malignancy; Ovarian tumors; Prediction; Stage; Sulfatides

Indexed keywords

SULFATIDE; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CELL TYPE; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; OVULATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 1442274995     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2004.014223.x-1     Document Type: Article

References (14)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
2. Greene MH, Clark JW, Blayney DW. The epidemiology of ovarian cancer. Semin Oncol 1984;11:209-26.
3. Roberts DD, Rao CN, Liotta LA, Gralnick HR, Ginsberg V. Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem 1986;261:6872-7.
4. Sakakibara N, Gasa S, Kamio K, Makita A, Koyanagi T. Association of elevated sulfatides and sulfotransferase activities with human renal cell carcinoma. Cancer Res 1989;49:335-9.
5. Yoda Y, Gasa S, Makita A, Fujioka Y, Kikuchi Y, Hashimoto M. Glycolipids in human lung carcinoma of histologically different types. J Natl Cancer Inst 1979;63: 1153-60.
6. Morichika H, Hamanaka Y, Tai T, Ishizuka I. Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer 1996; 78:43-7.
7. FIGO (International Federation of Gynecology and Obstetrics). Changes in definition of clinical staging for carcinoma of the cervix and the ovary. Am J Obstet Glynecol 1987;156:263-4.
8. Kean EL. Rapid sensitive spectrophotometric method for quantitative determination of sulfatides. J Lipid Res 1968; 9:319-27.
9. Hiraiwa M, Taylor EM, Campana WM, Darin SJ, O'Brien JS. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc Natl Acad Sci USA 1997;94:4778-81.
10. Balbaa M, Honke K, Makita A. Regulation of glycolipid sulfotransferases by tyrosine kinases in human renal cell cancer cells. Biochim Biophys Acta 1996;1299:141-5.
11. Berchuck A, Rodriguez GC, Kamel A et al. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol 1991;164:669-74.
12. Fathalla MF. Incessant ovulation and ovarian tumours. Lancet 1972 [letter].
13. Capo-Chichi CD, Smith ER, Yang DH et al. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer 2002;95:1802-15.
14. Aoki S, Nakanishi Y, Akimoto S et al. Prognostic significance of laminin-5 gamma2 chain expression in colorectal carcinoma: immunohistochemical analysis of 103 cases. Dis Colon Rectum 2002;45:1520-7.